Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDINAVIR for Antiretroviral therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 44 adverse event reports in the FDA FAERS database where INDINAVIR was used for Antiretroviral therapy.

Most Reported Side Effects for INDINAVIR

Side Effect Reports % Deaths Hosp.
Lipodystrophy acquired 195 26.8% 0 19
Eyelid ptosis 158 21.7% 0 0
Mitochondrial toxicity 156 21.4% 0 0
Diplopia 155 21.3% 0 0
Virologic failure 100 13.7% 3 19
Drug resistance 93 12.8% 4 9
Viral mutation identified 93 12.8% 0 2
Pathogen resistance 85 11.7% 0 16
Dysphagia 82 11.3% 0 0
Foetal exposure during pregnancy 76 10.4% 2 29
Progressive external ophthalmoplegia 74 10.2% 0 0
Ophthalmoplegia 58 8.0% 0 0
Blood lactic acid increased 54 7.4% 0 12
Treatment failure 42 5.8% 0 0
Drug ineffective 40 5.5% 1 6

Other Indications for INDINAVIR

Hiv infection (536) Product used for unknown indication (67) Acquired immunodeficiency syndrome (11) Chronic hepatitis c (5)

Other Drugs Used for Antiretroviral therapy

LAMIVUDINE (848) EFAVIRENZ (580) NEVIRAPINE (460) ZIDOVUDINE (458) RITONAVIR (447) ATAZANAVIR (419) LOPINAVIR\RITONAVIR (376) TENOFOVIR DISOPROXIL (358) RALTEGRAVIR (353) EMTRICITABINE\TENOFOVIR DISOPROXIL (287)

Related Pages

INDINAVIR Full Profile All Antiretroviral therapy Drugs INDINAVIR Demographics INDINAVIR Timeline